Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia

Journal of Leukocyte Biology

Volumn 96, Issue 1, 2014, Pages 83-91

  Sadras, Teresa ^a,b,d,g   Perugini, Michelle ^a,b,e   Kok, Chung H ^a,b,e   Iarossi, Diana G ^a,b,g   Heatley, Susan L ^a,c   Brumatti, Gabriela ^f   Samuel, Michael S ^a,d,e   To, Luen B ^b,e   Lewis, Ian D ^a,b,e   Lopez, Angel F ^a,c,e   Ekert, Paul G ^f   Ramshaw, Hayley S ^a,c   D'Andrea, Richard J ^a,b,d,e,g  

^a CENTRE FOR CANCER BIOLOGY   (Australia)

^b Haematology Department   (Australia)

^c Immunology Department   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e UNIVERSITY OF ADELAIDE   (Australia)

^f WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^g UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Gene expression profiling; Hox; Leukemic stem cell

Indexed keywords

BETA CATENIN; CRE RECOMBINASE; INTERLEUKIN 3; STAT5A PROTEIN; STAT5B PROTEIN; T CELL FACTOR PROTEIN; T CELL FACTOR PROTEIN 4; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HOX GENE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

GENE-EXPRESSION PROFILING; HOX; LEUKEMIC STEM CELL;

ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BETA CATENIN; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, LEUKEMIC; HOMEODOMAIN PROTEINS; HUMANS; INTERLEUKIN-3; LEUKEMIA, MYELOID, ACUTE; MICE; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; WNT SIGNALING PATHWAY;

EID: 84903544386     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.2AB1013-559R     Document Type: Article

References (43)

1. Giles, F. J., Keating, A., Goldstone, A. H., Avivi, I., Willman, C. L., Kantarjian, H. M. (2002) Acute myeloid leukemia. Hematology Am. Soc. Hematol. Educ. Program, 73-110.
2. Simon, M., Grandage, V. L., Linch, D. C., Khwaja, A. (2005) Constitutive activation of the Wnt/β-catenin signalling pathway in acute myeloid leukaemia. Oncogene 24, 2410-2420.
3. Ysebaert, L., Chicanne, G., Demur, C., De Toni, F., Prade-Houdellier, N., Ruidavets, J. B., Mansat-De Mas, V., Rigal-Huguet, F., Laurent, G., Payrastre, B., Manenti, S., Racaud-Sultan, C. (2006) Expression of β-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis. Leukemia 20, 1211-1216.
4. Chen, C. C., Gau, J. P., You, J. Y., Lee, K. D., Yu, Y. B., Lu, C. H., Lin, J. T., Lan, C., Lo, W. H., Liu, J. M., Yang, C. F. (2009) Prognostic significance of β-catenin and topoisomerase IIα in de novo acute myeloid leukemia. Am. J. Hematol. 84, 87-92.
5. Muller-Tidow, C., Steffen, B., Cauvet, T., Tickenbrock, L., Ji, P., Diederichs, S., Sargin, B., Kohler, G., Stelljes, M., Puccetti, E., Ruthardt, M., deVos, S., Hiebert, S. W., Koeffler, H. P., Berdel, W. E., Serve, H. (2004) Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Mol. Cell. Biol. 24, 2890-2904.
6. Tickenbrock, L., Schwable, J., Wiedehage, M., Steffen, B., Sargin, B., Choudhary, C., Brandts, C., Berdel, W. E., Muller-Tidow, C., Serve, H. (2005) Flt3 tandem duplication mutations cooperate with Wnt signaling in leukemic signal transduction. Blood 105, 3699-3706.
7. Valencia, A., Roman-Gomez, J., Cervera, J., Such, E., Barragan, E., Bolufer, P., Moscardo, F., Sanz, G. F., Sanz, M. A. (2009) Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia. Leukemia 23, 1658-1666.
8. Roman-Gomez, J., Cordeu, L., Agirre, X., Jimenez-Velasco, A., San Jose-Eneriz, E., Garate, L., Calasanz, M. J., Heiniger, A., Torres, A., Prosper, F. (2007) Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. Blood 109, 3462-3469.
9. Majeti, R., Becker, M. W., Tian, Q., Lee, T. L., Yan, X., Liu, R., Chiang, J. H., Hood, L., Clarke, M. F., Weissman, I. L. (2009) Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. Proc. Natl. Acad. Sci. USA 106, 3396-3401.
10. Gandillet, A., Park, S., Lassailly, F., Griessinger, E., Vargaftig, J., Filby, A., Lister, T. A., Bonnet, D. (2011) Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation. Leukemia 25, 770-780.
11. Wang, Y., Krivtsov, A. V., Sinha, A. U., North, T. E., Goessling, W., Feng, Z., Zon, L. I., Armstrong, S. A. (2010) The Wnt/β-catenin pathway is required for the development of leukemia stem cells in AML. Science 327, 1650-1653.
12. Yeung, J., Esposito, M. T., Gandillet, A., Zeisig, B. B., Griessinger, E., Bonnet, D., So, C. W. (2010) β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells. Cancer Cell 18, 606-618.
13. Jordan, C. T., Upchurch, D., Szilvassy, S. J., Guzman, M. L., Howard, D. S., Pettigrew, A. L., Meyerrose, T., Rossi, R., Grimes, B., Rizzieri, D. A., Luger, S. M., Phillips, G. L. (2000) The interleukin-3 receptor α chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia 14, 1777-1784.
14. Testa, U., Riccioni, R., Militi, S., Coccia, E., Stellacci, E., Samoggia, P., Latagliata, R., Mariani, G., Rossini, A., Battistini, A., Lo-Coco, F., Peschle, C. (2002) Elevated expression of IL-3Rα in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis. Blood 100, 2980-2988.
15. Du, X., Ho, M., Pastan, I. (2007) New immunotoxins targeting CD123, a stem cell antigen on acute myeloid leukemia cells. J. Immunother. 30, 607-613.
16. Jin, L., Lee, E. M., Ramshaw, H. S., Busfield, S. J., Peoppl, A. G., Wilkinson, L., Guthridge, M. A., Thomas, D., Barry, E. F., Boyd, A., Gearing, D. P., Vairo, G., Lopez, A. F., Dick, J. E., Lock, R. B. (2009) Monoclonal antibody-mediated targeting of CD123, IL-3 receptor α chain, eliminates human acute myeloid leukemic stem cells. Cell. Stem Cell 5, 31-42.
17. Kuo, S. R., Wong, L., Liu, J. S. (2012) Engineering a CD123×CD3 bispecific scFv immunofusion for the treatment of leukemia and elimination of leukemia stem cells. Protein Eng. Des. Sel. 25, 561-569.
18. Yalcintepe, L., Frankel, A. E., Hogge, D. (2006) Expression of interleukin-3 receptor subunits on defined subpopulations of acute myeloid leukemia blasts predicts the cytotoxicity of diphtheria toxin interleukin-3 fusion protein against malignant progenitors which engraft in immunodeficient mice. Blood 108, 3530-3537.
19. Martinez-Moczygemba, M., Huston, D. P. (2003) Biology of common β receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J. Allergy Clin. Immunol. 112, 653-665.
20. Evans, C. A., Pierce, A., Winter, S. A., Spooncer, E., Heyworth, C. M., Whetton, A. D. (1999) Activation of granulocyte-macrophage colonystimulating factor and interleukin-3 receptor subunits in a multipotential hematopoietic progenitor cell line leads to differential effects on development. Blood 94, 1504-1514.
21. Bryder, D., Jacobsen, S. E. (2000) Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro. Blood 96, 1748-1755.
22. Delwel, R., Dorssers, L., Touw, I., Wagemaker, G., Lowenberg, B. (1987) Human recombinant multilineage colony stimulating factor (interleukin-3): stimulator of acute myelocytic leukemia progenitor cells in vitro. Blood 70, 333-336.
23. Vellenga, E., Young, D. C., Wagner, K., Wiper, D., Ostapovicz, D., Griffin, J. D. (1987) The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood 69, 1771-1776.
24. Budel, L. M., Touw, I. P., Delwel, R., Clark, S. C., Lowenberg, B., Murohashi, I., Tohda, S., Suzuki, T., Nagata, K., Yamashita, Y., Nara, N. (1989) Interleukin-3 and granulocyte-monocyte colony-stimulating factor receptors on human acute myelocytic leukemia cells and relationship to the proliferative response. Blood 74, 565-571.
25. Perkins, A., Kongsuwan, K., Visvader, J., Adams, J. M., Cory, S. (1990) Homeobox gene expression plus autocrine growth factor production elicits myeloid leukemia. Proc. Natl. Acad. Sci. USA 87, 8398-8402.
26. Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., Mesirov, J. P. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-15550.
27. Ekert, P. G., Read, S. H., Silke, J., Marsden, V. S., Kaufmann, H., Hawkins, C. J., Gerl, R., Kumar, S., Vaux, D. L. (2004) Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die. J. Cell Biol. 165, 835-842.
28. Baba, Y., Garrett, K. P., Kincade, P. W. (2005) Constitutively active β-catenin confers multilineage differentiation potential on lymphoid and myeloid progenitors. Immunity 23, 599-609.
29. Brown, A. L., Salerno, D. G., Sadras, T., Engler, G. A., Kok, C. H., Wilkinson, C. R., Samaraweera, S. E., Sadlon, T. J., Perugini, M., Lewis, I. D., Gonda, T. J., D'Andrea, R. J. (2012) The GM-CSF receptor utilizes β-catenin and Tcf4 to specify macrophage lineage differentiation. Differentiation 83, 47-59.
30. Kitamura, T., Tange, T., Terasawa, T., Chiba, S., Kuwaki, T., Miyagawa, K., Piao, Y. F., Miyazono, K., Urabe, A., Takaku, F. (1989) Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell. Physiol. 140, 323-334.
31. Sun, Q., Woodcock, J. M., Rapoport, A., Stomski, F. C., Korpelainen, E. I., Bagley, C. J., Goodall, G. J., Smith, W. B., Gamble, J. R., Vadas, M. A., Lopez, A. F. (1996) Monoclonal antibody 7G3 recognizes the Nterminal domain of the interleukin-3 (IL-3) receptor β-chain and functions as a specific IL-3 receptor antagonist. Blood 87, 83-92.
32. Broughton, S. E., Dhagat, U., Hercus, T. R., Nero, T. L., Grimbaldeston, M. A., Bonder, C. S., Lopez, A. F., Parker, M. W. (2012) The GM-CSF/ IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling. Immunol. Rev. 250, 277-302.
33. Mui, A. L., Wakao, H., Kinoshita, T., Kitamura, T., Miyajima, A. (1996) Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J. 15, 2425-2433.
34. Yen, J. J., Yang-Yen, H. F. (2006) Transcription factors mediating interleukin-3 survival signals. Vitam. Horm. 74, 147-163.
35. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., Kinzler, K. W. (1998) Identification of c-MYC as a target of the APC pathway. Science 281, 1509-1512.
36. Kok, C. H., Brown, A. L., Ekert, P. G., D'Andrea, R. J. (2010) Gene expression analysis reveals HOX gene upregulation in trisomy 8 AML. Leukemia 24, 1239-1243.
37. Mullighan, C. G., Kennedy, A., Zhou, X., Radtke, I., Phillips, L. A., Shurtleff, S. A., Downing, J. R. (2007) Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias. Leukemia 21, 2000-2009.
38. Liu, Y. C., Lai, W. C., Chuang, K. A., Shen, Y. J., Hu, W. S., Ho, C. H., Chen, Y. B., Hsu, M. F., Hsu, H. C., Lieu, C. H. (2010) Blockade of JAK2 activity suppressed accumulation of β-catenin in leukemic cells. J. Cell. Biochem. 111, 402-411.
39. Kida, A., Kakihana, K., Kotani, S., Kurosu, T., Miura, O. (2007) Glycogen synthase kinase-3β and p38 phosphorylate cyclin D2 on Thr280 to trigger its ubiquitin/proteasome-dependent degradation in hematopoietic cells. Oncogene 26, 6630-6640.
40. Maurer, U., Charvet, C., Wagman, A. S., Dejardin, E., Green, D. R. (2006) Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol. Cell 21, 749-760.
41. Irish, J. M., Hovland, R., Krutzik, P. O., Perez, O. D., Bruserud, O., Gjertsen, B. T., Nolan, G. P. (2004) Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118, 217-228.
42. Rosen, D. B., Putta, S., Covey, T., Huang, Y. W., Nolan, G. P., Cesano, A., Minden, M. D., Fantl, W. J. (2010) Distinct patterns of DNA damage response and apoptosis correlate with Jak/Stat and PI3kinase response profiles in human acute myelogenous leukemia. PLoS One 5, e12405.
43. Marvin, J., Swaminathan, S., Kraker, G., Chadburn, A., Jacobberger, J., Goolsby, C. (2011) Normal bone marrow signal-transduction profiles: a requisite for enhanced detection of signaling dysregulations in AML. Blood 117, e120-e130.